Skip to main content
. 2016 Feb 17;60:10.3402/fnr.v60.28373. doi: 10.3402/fnr.v60.28373

Fig. 6.

Fig. 6

Effect of chronic EGCG treatment on ex vivo colonic and duodenal motility. (a) Colonic contractile responses to carbachol (0.05–5 µM); (b) duodenal inhibitory response to electrical field stimulation (EFS; 1–10 Hz, 13 V, 1 msec, 10-sec train duration) in preparation pretreated with NG-nitro-l-arginine (L-NNA, 20 min, 100 µM). Values are expressed as mean±SEM of 6–8 experiments. **p<0.01 vs vehicle-treated WKY rats; *p<0.05 vs vehicle-treated SHR.